This webinar is pending approval from CAMPEP for 1 MPCEC hour and approved by ASRT for 1 category A credit.
In the upcoming webinar, we will be discussing:
- Guidelines for the treatment of non-metastatic anal cancer include the use of Intensity-modulated Radiotherapy (IMRT) or Volumetric Modulated Radiotherapy (VMAT) in association with chemotherapy.
- The use of highly conformal treatment of anal cancer- This is attractive because of the large treatment volumes adjacent to the small bowel and bladder as well as exposure of the skin in the gluteal fold to high doses. The excellent oncological outcomes of radio-chemotherapy in anal cancers are historically associated with related side effects: hematologic toxicity, skin reaction, gastrointestinal and genitourinary toxicity.
- The advantage of the TomoTherapy® System compared to the VMAT technique with a homogeneous Planning Target Volume (PTV) coverage, a simultaneous integrated boost (SIB) approach if indicated, and a daily Megavoltage CT imaging as part of image-guided radiotherapy (IGRT) to allow for bony and soft tissue alignment.
Presenter: Marianna Alessandra Gerardi, M.D., Radiation Oncologist, European Institute of Oncology, Milan, Italy
Dr. Gerardi was born in Turin. She received her medical degree in 2010 and her specialization in Radiation Oncology in 2016 at the University of Milan. Since 2016, she has been a Medical Assistant at the Radiotherapy Department of the European Institute of Milan (IEO-Italy). Her primary clinical interests include management of gastrointestinal and breast malignancies, oligometastatic disease and palliative cure.
Dr. Gerardi is increasingly interested in modern radiotherapeutic techniques, including Intensity-modulated radiotherapy, stereotactic cranial and extracranial treatments, and image-guided radiotherapy.
Since 2014, she has been conducting several teaching activities at the University of Milan. She actively takes part in several working groups. Specifically, she is a current member of the national gastrointestinal group of the Italian Society of Radiation Oncology (AIRO).
Dr. Gerardi has authored more than thirty articles in peer-reviewed journals.
Presenter: Raffaella Cambria, MSc., Deputy Director of the Medical Physics Department, European Institute of Oncology, Milan, Italy
Raffaella Cambria received her master’s degree in Nuclear Physics in 1990 at the Università degli Studi di Milano, and in the nine years that followed, was a researcher in the Italian Hadrontherapy Project, where her research centered around new dosimeters for clinical proton beams. In 1999, Mrs Cambria was hired as a senior assistant at the European Institute of Oncology (IEO) of Milan (Italy), directed by Dr R. Orecchia. She was appointed Deputy Director of the Medical Physics department in 2015. She is an expert in the latest radiotherapy techniques and planning, including IMRT, VMAT, stereotactic cranial and extracranial treatments, and image-guided radiotherapy. Mrs Cambria has authored more than ninety articles in peer-reviewed journals. She is an Associate Professor at the Università degli Studi di Milano, both for the postgraduate radiotherapy school of medicine and radiotherapy technicians.
Moderator: Barbara Alicja Jereczek-Fossa, M.D., Ph.D., Full Professor of Radiation Oncology, University of Milan, Italy. Head of the Department of Radiation Oncology, European Institute of Oncology, Milan, Italy
Barbara Alicja Jereczek-Fossa, M.D., Ph.D., is currently a Full Professor of Radiation Oncology at the Department of Oncology and Hemato-oncology at the University of Milan and Chair of the Department of Radiation Oncology at the European Institute of Oncology IRCCS (IEO), Milan, Italy.
Prof. Jereczek-Fossa is actively involved in numerous educational and research activities, both at national and international level. She is an active member of numerous scientific societies, committees and editorial boards. She regularly participates in scientific meetings, consensus meetings (including the Advance Prostate Cancer Consensus Conference), and guidelines task forces.
Prof. Jereczek-Fossa is a Chair of the National Societies Committee of the European Society of Radiotherapy and Oncology (ESTRO) and coordinates the Education Committee of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Her research regards mainly urological and breast malignancies, innovation in radiation oncology (SBRT, IGRT, proton therapy etc.), combined drug-radiation treatment, AI & radiomics.
Prof. Jereczek-Fossa is the author of over 460 peer-reviewed scientific papers and eight book chapters, a member of the Stanford University list of most cited scientists (World’s Top 2% Scientists) since 2022, and a member of the Top Italian Scientists list – TIS list.
Total impact factor (IF): 1778.722 (mean IF: *: 3.875/article)
H-index (according to Google Scholar): 54
Author ID: 7004306533
